NEUROCRINE BIOSCIENCES INC Quarterly Amortization of Intangible Assets in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Neurocrine Biosciences Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2022 to Q1 2024.
  • Neurocrine Biosciences Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $900K, unchanged year-over-year.
  • Neurocrine Biosciences Inc annual Amortization of Intangible Assets for 2023 was $3.5M, a 600% increase from 2022.
  • Neurocrine Biosciences Inc annual Amortization of Intangible Assets for 2022 was $500K.
  • Neurocrine Biosciences Inc annual Amortization of Intangible Assets for 2021 was $0.000.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $900K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 $900K +$900K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.